Bladder Cancer News

  • Good Gut Microbes May Help Immunotherapy Drugs Shrink Tumors Cancer patients with high levels of good gut bacteria appear more likely to respond to immunotherapy, potentially opening up a new way to optimize the use of modern medicines that are highly effective but only work in some people.
  • UK's NICE Gives Roche Drug Green Light for Bladder Cancer Britain's healthcare cost-effectiveness agency NICE, which decides if medicines should be used on the state health service, has decided Roche's immunotherapy drug Tecentriq is worth using to treat certain patients with bladder cancer.

Bladder Cancer Perspective


Bladder Cancer Journal Articles